Disclosures for "Adherence and Safety of Intravenous Inebilizumab for NMOSD: Real-world Evidence from China"
-
Dr. Zhang has nothing to disclose.
-
Dr. Wang has nothing to disclose.
-
Mr. Chen has nothing to disclose.
-
The institution of Miss Shi has received research support from NIH.
-
Prof. Du has nothing to disclose.
-
Prof. Zhou has nothing to disclose.